Latest medical findings

Evidence-based insights from our clinical team.

Filter by topic:

A systematic review on the effectiveness of medical training therapy for subacute and chronic low back pain.

Medical training therapy (MTT) shows moderate evidence for reducing pain and improving function in chronic low back pain, but more high-quality trials are needed to compare it directly to other exercise therapies.
Result: Medical training therapy (MTT) shows moderate evidence for reducing pain and improving function in chronic low back pain, but more high-quality trials are needed to compare it directly to other exercise therapies.

Identification of International Classification of Functioning, Disability and Health Categories for Patients with Peripheral Arterial Disease

This study identifies key ICF categories for peripheral arterial disease, linking physiological markers to muscle endurance, and patient-reported quality of life to emotional and daily functional factors.
Result: This study identifies key ICF categories for peripheral arterial disease, linking physiological markers to muscle endurance, and patient-reported quality of life to emotional and daily functional factors.

Is suprascapular neuropathy common in high-performance beach volleyball players? A retrospective analysis

Muscle atrophy in elite beach volleyball players may stem from biomechanical factors rather than true suprascapular neuropathy, as electrophysiological testing of symptomatic athletes showed no nerve lesions.
Result: Muscle atrophy in elite beach volleyball players may stem from biomechanical factors rather than true suprascapular neuropathy, as electrophysiological testing of symptomatic athletes showed no nerve lesions.

Long-Term Effects of Severe Burn Injury on Bone Turnover and Microarchitecture

Severe burn injuries trigger long-term bone loss and microstructural deterioration that persist for up to 24 months, highlighting the need for early bone-protective strategies during rehabilitation.
Result: Severe burn injuries trigger long-term bone loss and microstructural deterioration that persist for up to 24 months, highlighting the need for early bone-protective strategies during rehabilitation.

Myostatin and other musculoskeletal markers in lung transplant recipients

Even as physical function improves after lung transplantation, persistent abnormalities in biomarkers like myostatin highlight the ongoing need for targeted, long-term musculoskeletal rehabilitation.
Result: Even as physical function improves after lung transplantation, persistent abnormalities in biomarkers like myostatin highlight the ongoing need for targeted, long-term musculoskeletal rehabilitation.

Myostatin and markers of bone metabolism in dermatomyositis

Patients with dermatomyositis exhibit altered biochemical markers of muscle and bone metabolism alongside functional deficits, highlighting the need for targeted, multi-modal rehabilitation.
Result: Patients with dermatomyositis exhibit altered biochemical markers of muscle and bone metabolism alongside functional deficits, highlighting the need for targeted, multi-modal rehabilitation.

Bone Stress Injuries Are Associated With Differences in Bone Microarchitecture in Male Professional Soldiers

Male soldiers with tibial bone stress injuries exhibit significant deficits in bone microarchitecture, including reduced cortical density and thinner, more irregular trabecular networks.
Result: Male soldiers with tibial bone stress injuries exhibit significant deficits in bone microarchitecture, including reduced cortical density and thinner, more irregular trabecular networks.

Therapeutic apheresis: An effective strategy for a combined targeting of circulating lipoproteins, inflammatory markers, PFAS, and microplastics in cardiometabolic and neurodegenerative disease?

Therapeutic apheresis shows promise as a multi-target therapy to reduce circulating lipoproteins, inflammatory markers, and environmental toxins like PFAS and microplastics in chronic disease.
Result: Therapeutic apheresis shows promise as a multi-target therapy to reduce circulating lipoproteins, inflammatory markers, and environmental toxins like PFAS and microplastics in chronic disease.

Start your recovery today

Contact us